Medtronic plc (MDT) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
the bull case· 3
2
customers naming MDT as a supplier in their own filings
sec filingsfrom their filings9
of the funds on file reporting a position in MDT
n-portas of Jun 30 '26+0.08%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 3
10 of 22
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '265 of 8
recent reports where the move came in under the options-implied range
earnings historyimplied vs realized81
managers whose positions together make up four fifths of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Dec 1 '26 report. Not a forecast, not advice.
Of the 6 companies Medtronic plc moves with most closely, none share its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3845, Electromedical & Electrotherapeutic Apparatus, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
MDT (Medtronic plc) has 4 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Medtronic plc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Electromedical & Electrotherapeutic Apparatus
High 92.89 at 10:15 am ET, low 92.20 at 3:45 pm ET.
2,138 managers report a position worth $86.6B between them, and 81 of them hold 80% of it.